Pacira | PCRX - Ebitda

Stock Price
20.91
Daily Change
-0.11 -0.52%
Monthly
-16.69%
Yearly
-22.81%
Q1 Forecast
19.91

Pacira reported $49.36M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Astellas Pharma JPY 183.68B 31.98B Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
J&J USD 9.52B 389M Sep/2025
Ligand Pharmaceuticals USD 20.9M 61.44M Jun/2025
Novo Nordisk DKK 37.3B 5.86B Dec/2025
Pacira USD 49.36M 4.96M Sep/2025
Perrigo USD 258.8M 37.3M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Supernus Pharmaceuticals USD 41.9M 432K Sep/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025
Zoetis USD 1.04B 87M Sep/2025